U.S. Personal Products Stock News

Recent performance snapshot for Philip Morris International (PM) Philip Morris International (PM) has drawn investor attention after recent share price weakness, with a 7 day return of about a 7% decline and a one month return of roughly an 11% decline from its last close of $163.11. See our latest analysis for Philip Morris International. The recent 7-day and 30-day share price declines sit against a steadier picture, with a modestly positive year-to-date share price return and a stronger...

Why fresh concerns around Post Holdings (POST) are back in focus Recent bearish commentary on Post Holdings (POST) has zeroed in on declining U.S. cereal consumption, tougher competition from alternative breakfast options, and expectations of margin pressure and slower organic growth. See our latest analysis for Post Holdings. Post Holdings' recent share price weakness, including a 9.4% 1 month share price return and a 13.25% 1 year total shareholder return, suggests sentiment has cooled even...

Biogen (BIIB) is back in focus after Eisai and the company shared new real-world data at AD/PD 2026, showing that many patients remain on Alzheimer’s drug lecanemab beyond the initial 18-month treatment period. See our latest analysis for Biogen. Despite the positive lecanemab and pipeline headlines in recent weeks, Biogen’s share price has eased, with a 1-month share price return of a 5.5% decline and a 7-day return of a 1% decline, while the 1-year total shareholder return of 28.15%...

Why Brinker International (EAT) is Catching Investor Attention Now Brinker International (EAT) is back on many watchlists after recent share price weakness, with negative returns over the past week, month, past 3 months and year prompting fresh questions about valuation and earnings power. See our latest analysis for Brinker International. Despite the recent share price weakness, with the latest close at US$143.40 and a year to date share price decline of 5.36%, the three year total...

Mineralys Therapeutics, Inc. recently reported that its 2025 fourth-quarter net loss narrowed to US$32.23 million from US$48.95 million a year earlier, while the U.S. FDA accepted its New Drug Application for lorundrostat in adult hypertension with a PDUFA action date of December 22, 2026. The combination of reduced annual net loss to US$154.65 million and FDA review acceptance for lorundrostat marks a shift toward a more advanced, late-stage profile for Mineralys as it moves closer to a...

Palantir Technologies (NasdaqGS:PLTR) is expanding its AI platforms into new real-world uses across aerospace, industrials, sports data, and financial services. Recent partnerships include multi-domain ISR work with Ondas and World View, AI transformation projects across LG Group, and nuclear fuel manufacturing optimization with Centrus Energy. The company is also building a next generation sports integrity platform with Polymarket, targeting fraud detection and market integrity in sports...

In March 2026, Ford Motor Company announced a long-term agreement with Bread Financial to launch a co-branded Ford Rewards Visa Signature credit card and integrated installment loan program, offering Points-based rewards and embedded financing for accessories, service, subscriptions and more across Ford’s online and dealership channels nationwide. By combining data-driven insights with Ford’s existing loyalty ecosystem, the partnership positions Bread Financial as a key enabler of more...

SS Innovations International, Inc. reported past 2025 results showing full-year revenue rising to US$42.48 million from US$20.65 million, while narrowing its net loss to US$12.13 million and disclosing auditor concerns about its ability to continue as a going concern. Separately, the company’s SSi Mantra surgical robotic system secured approval for telesurgeries in Indonesia and the Philippines and passed 150 cumulative telesurgeries, signaling expanding real-world use of its technology...

Vishay Intertechnology recently introduced the SGCM05339, a space-grade surface-mount common mode choke designed for EMI filtering and noise suppression in demanding space, aerospace, defense, power conversion, and solar applications, featuring a rugged nanocrystalline core, high current capability up to 14.43 A, and operation from -55 °C to +130 °C. By combining space-qualified screening options such as MIL-PRF-27 and MIL-STD-981 with customizable electrical characteristics, the SGCM05339...

If you are wondering whether Silicon Motion Technology's share price still makes sense after a strong run, the key question is how its current market price compares with a grounded estimate of value. The stock last closed at US$123.76, with returns of 0.4% over 7 days, an 8.2% decline over 30 days, and gains of 32.0% year to date and 127.5% over 1 year. Recent coverage has focused on Silicon Motion Technology as a semiconductor name that has attracted attention after its strong 1-year share...

Bausch + Lomb recently held a special call to discuss two glaucoma assets and deeper insights into its differentiated product pipeline, following the unveiling of this pipeline in November 2025. Alongside this, CEO and Chairman Brenton L. Saunders’ presentation at the Longwood Healthcare Leaders Miami conference highlighted management’s effort to spotlight innovation and future product opportunities to a healthcare-focused investor audience. We will now explore how the focused glaucoma call...

Earlier in March 2026, Element U.S. Space & Defense announced a collaboration with Leonardo DRS to install a semi-anechoic electromagnetic interference chamber at Leonardo DRS’s Menomonee Falls, WI facility, aiming to expand high-power EMI testing capacity for U.S. Navy systems from the first quarter of 2026. The partnership is expected to create one of the most advanced EMI test facilities in the U.S., potentially tightening Leonardo DRS’s role in validating mission-critical naval power...

In March 2026, Alibaba Group Holding Limited reported its fiscal third-quarter and nine‑month 2025 results, showing sales rising slightly to CNY 284,843 million for the quarter and CNY 780,290 million for nine months, while net income fell sharply to CNY 16,383 million and CNY 78,051 million respectively versus the prior year. The earnings release highlighted how heavy spending on artificial intelligence and cloud infrastructure, alongside quick commerce expansion and a major shift away from...

Why recent caution around Impinj (PI) is back in focus Recent commentary on Impinj (PI) has centered on projected sales growth deceleration, ongoing operating margin losses, and negative returns on capital, at a time when the stock still trades on a relatively high P/E multiple. See our latest analysis for Impinj. At a share price of US$98.11, Impinj has seen a 23.3% 1 month share price decline and a 45.4% year to date share price decline. At the same time, the 1 year total shareholder return...

TXNM Energy stock moves without a clear headline catalyst TXNM Energy (TXNM) shares have been edging lower recently, even without a specific news event driving the move. This leaves investors weighing the utility's current valuation against its recent return profile. See our latest analysis for TXNM Energy. TXNM Energy's recent softness in the share price, with a 30 day share price return of 1.66% and a year to date share price return of a 1.66% decline, contrasts with a 1 year total...

VEON Ltd. recently reported its fourth-quarter and full-year 2025 results, showing higher group revenue, alongside updated 2026 guidance and confirmation of continued share buybacks, while also outlining expansion in digital services and asset-light initiatives. In March 2026, VEON also announced a wave of leadership changes across Beeline Uzbekistan and Kazakhstan and a new Group Chief Payments & Digital Assets Officer, underscoring its push into financial services, digital assets and...

Recent stock performance and what it might signal Tyra Biosciences (TYRA) has drawn attention after a 2.7% decline in the last session, following a sharp move over the past 3 months that left the stock up 46.4%. Over the past month the shares are up 17.6%, while the 1 year total return stands at 247.5%, set against a recent closing price of US$37.15 and a market value of about US$2.0b. See our latest analysis for Tyra Biosciences. Put simply, Tyra Biosciences has combined sharp short term...

Shield launch in Asia puts Guardant Health in focus Guardant Health (GH) is in the spotlight after announcing a partnership with Manulife to offer its Shield multi cancer detection blood test to eligible customers in Hong Kong, Singapore and the Philippines starting in April 2026. See our latest analysis for Guardant Health. Despite the Shield news, Guardant Health’s 1-day share price return of a 4.38% decline and 30-day share price return of a 17.38% decline sit alongside a 1-year total...

In early February 2026, Jack Henry & Associates reported Q2 2026 results showing 7.9% revenue growth and higher profit, with services and support revenue up 7.1% and processing revenue up 9.1%, underscoring solid demand across its banking technology and payments businesses. The broad-based growth across both services and processing suggests that financial institutions are continuing to invest in Jack Henry’s core platforms rather than pausing or cutting technology spending. We’ll now explore...

Recent Share Performance and Business Snapshot Tractor Supply (TSCO) has drawn attention after a recent pullback, with the share price down about 14% over the past month and roughly 10% over the past 3 months. The rural lifestyle retailer reports annual revenue of about US$15.5b and net income of roughly US$1.1b, serving recreational farmers, ranchers, and pet owners across the United States through its Tractor Supply Company and Petsense formats. See our latest analysis for Tractor...

For investors wondering whether Guidewire Software at around US$155 still offers value or if most of the upside is already reflected in the price, this article walks through that question using multiple valuation lenses. The stock has recently been volatile, with a 21.9% gain over the last 30 days, a 3.8% decline over the past week, and returns of 21.2% decline over 1 year compared with gains of 103.5% over 3 years and 52.3% over 5 years. These mixed return periods suggest shifting views...

AECOM (ACM) has attracted attention after recent share moves, with the stock closing at $88.58. Investors are weighing its current valuation against recent returns and the scale of its global infrastructure business. See our latest analysis for AECOM. Recent trading has been softer, with a 1 day share price return showing a 1.93% decline and a 30 day share price return showing a 9.51% decline. However, the 5 year total shareholder return of 45.19% points to a much stronger longer run outcome...

This article considers whether Flowco Holdings at around US$21.69 could be a bargain or a value trap by focusing on what the current share price might imply about the company. The stock has returned approximately 14.0% year to date, but it has seen a 5.0% decline over 7 days and a 6.9% decline over 30 days, while the 1-year return reflects a 15.4% decline. Recent coverage has highlighted Flowco Holdings as an energy services company in a sector where investor sentiment can shift quickly with...

Why Varonis Systems (VRNS) is back on investors’ radar Varonis Systems (VRNS) has drawn fresh attention after reporting 9.4% year on year revenue growth and 32% SaaS ARR growth, while issuing full year EPS guidance that came in below market expectations. The company also launched its new Varonis Atlas AI Security Platform and is presenting at RSA Conference 2026. These developments are prompting investors to reassess the stock after its post earnings share price decline. See our latest...